DNAnexus
- 09/06/2022
- Unknown
- $100,000,000
DNAnexus combines expertise in cloud computing and bioinformatics to create the global network for genomic medicine. DNAnexus provides security, scalability, and collaboration for enterprises and organizations that are pursuing genomic-based approaches to health in order to accelerate medical discovery. DNAnexus is supporting customers around the world that are tackling some of the most challenging and exciting opportunities in human health.For more information, please visit: https://dnanexus.com and follow us at @DNAnexus.
- Industry Biotechnology
- Website https://www.dnanexus.com/
- LinkedIn https://www.linkedin.com/company/dnanexus/
Related People
Serafim BatzoglouCo Founder
Dr. Serafim Batzoglou is SVP of Data at Seer Bio, leading the computational and ML teams to advance the core proteomics technology and its biomedical applications.
Prior to this role he was chief data officer at insitro, VP at Illumina, and professor of Computer Science at Stanford University.
His work has focused on computational genomics and the application of algorithms & AI to diverse problems in biosciences ranging from genome assembly, comparative genomics, population genetics, cancer genomics and genome sequencing technologies.
He is co-founder of DNAnexus and has been at several scientific advisory boards including those of 23andMe, NextBio, DNAnexus, Eve Biomedical, Genapsys and Moleculo. In 2003 he was named among the top young technology innovators by Technology Review magazine. He received the inaugural Innovator Award by the International Society of Computational Biology (ISCB) in 2016, and was named an ISCB Fellow in 2020.